APPLICATION
ANDA219482
TYPE
ANDA
ORIGINAL APPROVAL
2025-05-12
LATEST ACTION
2025-05-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 1MG BASE · CAPSULE · ORAL
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 10MG BASE · CAPSULE · ORAL
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 2MG BASE · CAPSULE · ORAL
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 5MG BASE · CAPSULE · ORAL
Approval history
2025-05-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.